Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl]ethanoate for use in lymphangioleiomyomatosis and other diseases

[2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl]ethanoate for use in lymphangioleiomyomatosis and other diseases

US Patent 11547699 · Granted Jan 10, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Capture compounds, collections thereof and methods for analyzing the proteome an2015
Matrix-assisted laser desorption ionization mass spectrometry substrates having 2014
Methods for generating databases and databases for identifying polymorphic genet2014
Solid phase sequencing of biopolymers2014
Beads bound to a solid support and to nucleic acids2014
Capture compounds, collections thereof and methods for analyzing the proteome an2013
Methods for generating databases and databases for identifying polymorphic genet2012
Capture compounds, collections thereof and methods for analyzing the proteome an2010
Solid phase sequencing of biopolymers2010
Mass spectrometric methods for detecting mutations in a target nucleic acid2010
Methods for generating databases and databases for identifying polymorphic genet2010
Beads bound to a solid support and to nucleic acids2009